Beijing Foyou Pharma (601089.SH): Diquyuntan Tablets Obtained Drug Registration Certificate.
Fukuyuan Pharmaceuticals (601089.SH) announcement, the company's wholly-owned subsidiary Zhejiang Aisheng Pharmaceutical Co., Ltd. (referred to as "Zhejiang...
Beijing Foyou Pharma (601089.SH) announced that its wholly-owned subsidiary Zhejiang Aisheng Pharmaceutical Co., Ltd. (referred to as "Zhejiang Aisheng") has received the Drug Registration Certificate for Dienogest Tablets (10mg) issued by the National Medical Products Administration, approving the production of the drug. Dienogest is a synthetic progestin that can be taken orally and absorbed by the body.
Related Articles
US Stock Market Move | Amazon.com, Inc. (AMZN.US) is up more than 2%, with the company accelerating its automation process.
US Stock Market Move | Halliburton (HAL.US) rose more than 9% with Q3 results exceeding expectations.
ANHUIEXPRESSWAY(00995) plans to invest approximately 3.0187 billion yuan to acquire 7% equity of Shandong Hi-speed(600350.SH)
US Stock Market Move | Amazon.com, Inc. (AMZN.US) is up more than 2%, with the company accelerating its automation process.
US Stock Market Move | Halliburton (HAL.US) rose more than 9% with Q3 results exceeding expectations.
ANHUIEXPRESSWAY(00995) plans to invest approximately 3.0187 billion yuan to acquire 7% equity of Shandong Hi-speed(600350.SH)
RECOMMEND
Why European Automakers Are Opposing Dutch Sanctions
20/10/2025
Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025
Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025
